Med-Fine Capital
Venture capitalShanghai · Seed–Late Stage · 7 people tracked
Investment thesis
Early-stage healthcare and biotech investors backing China-based companies developing bispecific antibodies, ADCs, and T-cell engagers, offering tailored global expansion strategies and regional network ties including Southeast Asia.
Team · 7 people
from public directoriesFrequently asked questions
- What stage does Med-Fine Capital invest at?
- Med-Fine Capital invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Med-Fine Capital focus on?
- Med-Fine Capital focuses on Biotech, Healthtech, Medical Devices.
- Where is Med-Fine Capital located?
- Med-Fine Capital is headquartered in Shanghai, CN.
- Does Med-Fine Capital lead rounds?
- Med-Fine Capital typically participates in rounds rather than leading them.
Similar investors
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.